" /> Tuberous sclerosis 2 - CISMeF





Preferred Label : Tuberous sclerosis 2;

Symbol : TSC2;

CISMeF acronym : TSC2;

Type : Phenotype, molecular basis known;

Included titles and symbols : Tsc2 angiomyolipomas, renal, modifier of;

Description : Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized by hamartomas in multiple organ systems, including the brain, skin, heart, kidneys, and lung. These changes can result in epilepsy, learning difficulties, behavioral problems, and renal failure, among other complications (reviews by Crino et al., 2006 and Curatolo et al., 2008). For a general phenotypic description and a discussion of genetic heterogeneity of tuberous sclerosis, see tuberous sclerosis-1 (191100), caused by mutation in the TSC1 gene (605284) on chromosome 9q34. Approximately 10 to 30% of cases of tuberous sclerosis are due to mutations in the TSC1 gene: the frequency of cases due to mutations in the TSC2 gene is consistently higher. TSC2 mutations are associated with more severe disease (Crino et al., 2006) (see GENOTYPE/PHENOTYPE;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the tuberin gene (TSC2, 191092.0001);

Neoplasia : Myocardial rhabdomyoma; Multiple bilateral renal angiomyolipoma; Ependymoma; Renal carcinoma; Giant cell astrocytoma; Chordoma; Benign tumors of the eye, heart, and lungs;

Laboratory abnormalities : Increased frequency of premature centromere disjunction (PCD) in cultured fibroblasts, esp. chromosome 3; Allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma;

Prefixed ID : #613254;

Details


You can consult :


Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.